Federal Court Rules in ICAN’s Favor and Orders COVID-19 Safety Data to be Disclosed
After months of NIH objecting, and after seeking Court intervention, ICAN’s attorneys have won a motion which now forces the NIH to unredact and disclose safety-related data they tried to withhold from Moderna’s Phase 1 clinical trial report. As a result of a FOIA request, the National Institutes …
Read More